Baytacare Pharmaceutical Co., Ltd. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2018. For the quarter, the company reported turnover was RMB 7,097,000 against RMB 15,094,000 a year ago. Operating loss was RMB 7,525,000 against RMB 9,151,000 a year ago. Loss before income tax expense was RMB 7,838,000 against RMB 9,758,000 a year ago. Loss attributable to owners of the company was RMB 8,348,000 against loss attributable to owners of the company of RMB 9,593,000 a year ago. Basic and diluted of 0.01 cents against 1.1 cents a year ago. For the six months, the company reported turnover was RMB 7,097,000 against RMB 8,917,000 a year ago. Operating profit was RMB 867,000 against operating loss of RMB 2,444,000 a year ago. Profit before income tax expense was RMB 594,000 against loss before income tax expense of RMB 2,950,000 a year ago. Profit attributable to owners of the company was RMB 594,000 against loss attributable to owners of the company of RMB 2,950,000 a year ago. Net cash inflow from operating activities was RMB 1,304,000 against net cash inflow from operating activities of RMB 58,451,000 a year ago.